Nimodipine (Caraco Pharmaceutical Laboratories, Ltd.)


Welcome to the PulseAid listing for the Nimodipine drug offered from Caraco Pharmaceutical Laboratories, Ltd.. This Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Caraco Pharmaceutical Laboratories, Ltd.
NON-PROPRIETARY NAME: Nimodipine
SUBSTANCE NAME: NIMODIPINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2007-06-28
END MARKETING DATE: 0000-00-00


Nimodipine HUMAN PRESCRIPTION DRUG Details:

Item DescriptionNimodipine from Caraco Pharmaceutical Laboratories, Ltd.
LABELER NAME: Caraco Pharmaceutical Laboratories, Ltd.
DEA SCHEDULE:
ACTIVE STRENGTH: 30(mg/1)
START MARKETING DATE: 2007-06-28
END MARKETING DATE: 0000-00-00
PRODUCT ID: 57664-135_b9f244e4-bf34-4f84-9507-4a56e21b8d8e
PRODUCT NDC: 57664-135
APPLICATION NUMBER: ANDA077067

Other NIMODIPINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Health PackagingNimodipine
ANI Pharmaceuticals, Inc.Nimodipine
Arbor PharmaceuticalsNymalize
Ascend Laboratories, LLCNimodipine
Caraco Pharmaceutical Laboratories, Ltd.Nimodipine
Cardinal HealthNimodipine
Golden State Medical Supply, Inc.Nimodipine
HeritageNimodipine
Major PharmaceuticalsNimodipine
McKesson Packaging Services a business unit of McKesson CorporationNimodipine